October 22, 2024
Onsite Registration Opens in San Diego
October 23, 2024
Early Programs in San Diego
October 24-27, 2024
Annual Meeting
View All#KidneyWk on X 1 day ago
RT @NephroloTrish: Dr. @fervenzafernan1 educating us on new treatment strategies in IgA nephropathy; & reminding us that just like proteinu…
View Post
#KidneyWk on X 1 day ago
RT @ASNKidney: 💡 Have ideas for next year's world's premier nephrology meeting, #KidneyWk 2025? Share your suggestions by December 11, 2024…
View Post
#KidneyWk on X 1 day ago
RT @edgarvlermamd: Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Adults With 🔬 IgA Nephropathy (IgAN) in…
View Post
#KidneyWk on X 1 day ago
RT @edgarvlermamd: Patient-Reported Outcomes in the PROTECT Clinical Trial Comparing Sparsentan with Irbesartan for 🔬 IgA Nephropathy (IgA…
View Post
#KidneyWk on X 1 day ago
RT @hswapnil: my draft pick from #KidneyWk LBCT 2023 (a poster!), has now been published in @JASN_News https://t.co/ckINTB08Jw Lead by Ziv…
View Post
#KidneyWk on X 1 day ago
RT @edgarvlermamd: Concomitant Sparsentan (SPAR) and SGLT2 Inhibitors (SGLT2i) in Adults with 🔬 IgA Nephropathy (IgAN) in the Ongoing Phas…
View Post
#KidneyWk on X 1 day ago
RT @NephroloTrish: Dr. @fervenzafernan1 educating us on new treatment strategies in IgA nephropathy; & reminding us that just like proteinu…
View Post
#KidneyWk on X 1 day ago
RT @edgarvlermamd: Concomitant Sparsentan and Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i) in Adults With 🔬 IgA Nephropathy (IgAN) in…
View Post
#KidneyWk on X 1 day ago
RT @ASNKidney: 💡 Have ideas for next year's world's premier nephrology meeting, #KidneyWk 2025? Share your suggestions by December 11, 2024…
View Post
#KidneyWk on X 1 day ago
RT @edgarvlermamd: Concomitant Sparsentan (SPAR) and SGLT2 Inhibitors (SGLT2i) in Adults with 🔬 IgA Nephropathy (IgAN) in the Ongoing Phas…
View Post